Genotypic resistance testing of antiretrovirals in HIV
Medical Services Advisory Committee
Record Status
This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.
Citation
Medical Services Advisory Committee. Genotypic resistance testing of antiretrovirals in HIV. Canberra: Medical Services Advisory Committee (MSAC). MSAC application 1067. 2005
Authors' objectives
This assessment was undertaken to provide the broadest possible advice regarding the safety, effectiveness and cost-effectiveness of genotypic resistance testing for antiretrovirals in patients infected with human immunodeficiency virus (HIV).
Authors' conclusions
MSAC found that genotypic resistance testing of antiretrovirals in HIV appeared to be safe and leads to changes in clinical management but there is insufficient evidence on effectiveness and cost-effectiveness to support Medicare funding.